869901-73-5 Usage
Uses
Used in Pharmaceutical Industry:
EMPP is used as a building block in the synthesis of pharmaceuticals for its potential use as a drug in the treatment of various medical conditions such as neurological disorders and schizophrenia.
Used in Organic Synthesis:
EMPP is used as a reagent in organic synthesis due to its versatile chemical properties and ability to form a wide range of compounds.
Used in Agrochemical Production:
EMPP is used as an intermediate in the production of agrochemicals, contributing to the development of effective and efficient products for agricultural applications.
Used in Medicinal Chemistry:
EMPP is considered a valuable compound with diverse potential applications in the field of medicinal chemistry, offering opportunities for the discovery and development of new therapeutic agents.
Used in Chemical Engineering:
EMPP's diverse applications also extend to the field of chemical engineering, where it can be utilized in the design and synthesis of various chemical processes and products.
Check Digit Verification of cas no
The CAS Registry Mumber 869901-73-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,9,9,0 and 1 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 869901-73:
(8*8)+(7*6)+(6*9)+(5*9)+(4*0)+(3*1)+(2*7)+(1*3)=225
225 % 10 = 5
So 869901-73-5 is a valid CAS Registry Number.
InChI:InChI=1S/C7H14N2O.ClH/c1-3-9-5-6(2)8-4-7(9)10;/h6,8H,3-5H2,1-2H3;1H/t6-;/m0./s1
869901-73-5Relevant academic research and scientific papers
HIV INTEGRASE INHIBITORS
-
, (2008/06/13)
Hydroxy-substituted pyrazinopyrrolopyridazine dione compounds are inhibitors of HIV integrase and inhibitors of HIV replication. In one embodiment, the dione compounds are of Formula (I) wherein R1, R2, R3, R4, R5, R6 and R7 are defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
